ReviewRadiologie (Heidelberg, Germany)2022
[Cardiovascular consequences of smoking : Imaging overview].
Review in Radiologie (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Skin levels of advanced glycation end products in correlation with periodontal conditions - a pilot study.BMC oral health · 2026Article
- Candidate SNP Markers Significantly Altering the Affinity of TATA-Binding Protein for the Promoters of Human Hub Genes for Atherogenesis, Atherosclerosis and Atheroprotection.International journal of molecular sciences · 2023Article
- [Tobacco smoke-related diseases].Radiologie (Heidelberg, Germany) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical issueSmoking, which affects the whole cardiovascular system, primarily results in atheromatous plaques with risk of vascular stenosis or aneurysmatic vascular changes with risk of rupture. STANDARD RADIOLOGICAL
methodsDepending on location, sonography provides an initial assessment of alterations. Angiography in combination with computed tomography (CT) and magnetic resonance imaging (MRI) allows further evaluation and, if necessary, therapy planning. In smokers without clinical symptoms or additional risk factors, imaging only because of smoking is not recommended. METHODICAL INNOVATIONS: Recent guidelines of respective pathologies unanimously acknowledge smoking as modifiable risk factor for cardiovascular diseases; therefore, smoking cessation for prevention of secondary acute events is always recommended as the first step. In suspected chronic coronary syndrome, smoking increases clinical probability, which means that diagnostic imaging is often indicated earlier. PERFORMANCE: Although smoking causes extensive changes to the entire cardiovascular system, it remains to be evaluated whether smokers might profit from modification of current guidelines regarding prevention and diagnosis in terms of specific clinical events. PRACTICAL RECOMMENDATIONS: Due to increased cardiovascular risk, smokers should be advised to stop smoking. Regarding specific diseases, smoking does not fundamentally result in modification of imaging evaluation; however, in intermediate risk patients, further imaging can be recommended earlier in smokers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.